FDA Update: Romosozumab’s Uncertain Future; Plus Tocilizumab Approved for GCA
FDA Considers Tocilizumab for GCA & Piclidenoson Enters Phase 3 Trial for RA, Psoriasis
GCA Relapse Possible When Discontinuing Tocilizumab
ACR/ARP Annual Meeting
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.
Rheumatology Research Foundation
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
American College of Rheumatology
Visit the official website for the American College of Rheumatology.